SanBio, Inc.
USPTO PatentsView assignee record - 30 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Sanbio ranks #10,445 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 9 technology areas.
- #10,445
- of 49,997 US assignees by volume
- 49th percentile
- by Innovation Score (34.9/100)
- 14.7
- avg claims per patent
- -19%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10445 · US Corporation #10,445 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,445/49,997
- PHOTO-FINISH Sensible Medical…
- CPC-NARROW C12N · 9 areas
- INNOV-THIN 34.9/100
- CLAIMS-RICH 14.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -19% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sensible Medical Innovations Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Sanbio’s 34.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Sanbio
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Resvent Medical… · near
Resvent Medical… · near
35 score
- Rockstar Consortium US · near
Rockstar Consortium US · near
35 score
- Progress Profiles SPA · near
Progress Profiles SPA · near
35 score
- SanBio · this assignee
SanBio · this assignee
35 score
- Shenzhen Huion… · near
Shenzhen Huion… · near
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Sanbio's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Sanbio?
Each dot is one of Sanbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sanbio’s own 14.7 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Sanbio's grants concentrate
SanBio, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 90% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2018. By volume, Sanbio sits between Sonendo, Inc. and Shenzhen Breo Technology Co., Ltd..
Sanbio's three-year grant acceleration
SanBio, Inc. shows 7 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at SanBio's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sonendo
Sonendo, Inc.
30 patents
- SPX Cooling
SPX Cooling Technologies, Inc.
30 patents
- Structured I
Structured I, LLC
30 patents
- Suven Life Scienc…
Suven Life Sciences Limited
30 patents
- Sensible Medical…
Sensible Medical Innovations Ltd.
30 patents
- Sentry Solutions…
Sentry Solutions Products Group LLC
30 patents
- Sequent Medical
Sequent Medical, Inc.
30 patents
- Shenzhen Breo Tec…
Shenzhen Breo Technology Co., Ltd.
30 patents
- Sanbio ◀
SanBio, Inc.
30 patents
What this shows SanBio holds 30 patents at rank #10,457, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near SanBio
By rank, the assignees closest to #10,457 in granted patent volume.
- Sonendo, Inc. #10,453 · 30 patents
- SPX Cooling Technologies, Inc. #10,454 · 30 patents
- Structured I, LLC #10,455 · 30 patents
- Suven Life Sciences Limited #10,456 · 30 patents
- Sensible Medical Innovations Ltd. #10,458 · 30 patents
- Sentry Solutions Products Group LLC #10,459 · 30 patents
- Sequent Medical, Inc. #10,460 · 30 patents
- Shenzhen Breo Technology Co., Ltd. #10,461 · 30 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in SanBio's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for SanBio, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), SanBio ranks #400 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Sanbio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 6.7% |
| 2016 | 3 | 10.0% |
| 2017 | 3 | 10.0% |
| 2018 | 1 | 3.3% |
| 2019 | 7 | 23.3% |
| 2020 | 4 | 13.3% |
| 2021 | 2 | 6.7% |
| 2022 | 3 | 10.0% |
| 2024 | 4 | 13.3% |
| 2025partial year | 1 | 3.3% |
Which technologies does SanBio, Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
SanBio, Inc.'s patent record in context - here's where to go next.
- SanBio, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #10,445 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare SanBio, Inc. against Sonendo, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.